Anne Bresciani is the Head of New Modalities & Drug Discovery at Novo Nordisk, leveraging a deep background in bioinformatics from her previous leadership roles at ZS. She holds an M. Sc. Eng from the Technical University of Denmark and certifications in laboratory leadership and project management for scientists.
While a student, she received a scholarship co-sponsored by Novo Nordisk to complete her thesis at a leading immunology research institute in the United States, showing a long-standing connection to the company.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.